Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in CYTEK BIOSCIENCES INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 582 shares of CTKB (CYTEK BIOSCIENCES INC), worth $2,543 as of 2026-Q1. The position was decreased (-30.1% shares).
Current Value
$2,543
Current Shares
582
Total Value Change
-$1.1M
Total Shares Change
-198,571
Other major holders of CTKB: RA CAPITAL MANAGEMENT, L.P., HHLR ADVISORS, LTD., BlackRock Finance, Inc.
Decreased |
| 582 |
-30.1% |
| $2,543 |
| 0.0% |
| $4.44 |
0 |
| 2025-Q4 | New | 832 | - | $4,202 | 0.0% | $5.04 | 22 |
| 2025-Q3 | Exited | 0 | -100.0% | $0 | 0.0% | $3.38 | 0 |
| 2025-Q2 | Increased | 284,350 | +48.4% | $966,790 | 0.0% | $3.55 | 34 |
| 2025-Q1 | Decreased | 191,624 | -2.8% | $768,412 | 0.0% | $4.00 | 0 |
| 2024-Q4 | Increased | 197,058 | +12.8% | $1.3M | 0.0% | $6.55 | 29 |
| 2024-Q3 | Decreased | 174,625 | -12.3% | $967,423 | 0.0% | $5.39 | 0 |
| 2024-Q2 | Increased | 199,153 | +60.4% | $1.1M | 0.0% | $5.58 | 36 |